Telomerase is active in normal gastrointestinal mucosa and not up-regulated in precancerous lesions
Open accessThe DOI matches its Crossref record; 30 of the 30 references it cites were found in a registry or an index.
Abstract
Telomerase is a ribonucleoprotein complex which, by de novo synthesized telomeric TTAGGG repeats, prevents telomere erosion. While telomerase is active in most cancers, conflicting results exist for normal tissues and premalignant lesions. To establish the telomerase status of normal gastrointestinal mucosa and to elucidate whether telomerase up-regulation is an early or late event in carcinogenesis, we determined the telomerase activity of 88 biopsies of normal mucosa from esophagus, stomach, and intestine and compared it with that of 21 samples of premalignant lesions and 6 adenocarcinomas using the telomere-repeat amplification protocol assay. Telomerase was found in all normal tissues, revealing most activity in esophagus (11 samples), followed by intestine (45 samples), and stomach (32 samples). In 53% of the stomach samples, enzyme activity could only be demonstrated when telomerase inhibitors were eliminated by a modified telomerase assay. In the 21 precancerous lesions (5 Barrett's esophagus, 3 stomach intestinal metaplasias, and 13 colorectal adenomas of type I/II dysplasia) a similar or even reduced telomerase activity was seen, while the adenocarcinomas showed high activity. These data demonstrate that telomerase activity is expressed in all epithelia along the gastrointestinal tract, thus confirming our previous hypothesis that telomerase is constitutively expressed in permanently renewing epithelia. Furthermore, activity was not increased in preneoplastic lesions, suggesting that telomerase up-regulation is a late event during carcinogenesis of the esophagus, stomach, and intestine.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“However, more sensitive analysis of primary human samples has since revealed modest levels of telomerase activity in proliferative tissues with high renewal potential such as the bone marrow, skin, gastrointestinal tract and testis as well as in activated lymphocytes (49)(50)(51).”
From Telomeres and telomerase in cancer (2010) · cites this paper as [51]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A genetic model for colorectal tumorigenesis
Fearon, E. R., & Vogelstein, B. (1990) · Cell · doi:10.1016/0092-8674(90)90186-i · Cited by 12,132 · cited 2×
“…from normal epithelium to adenomas, and ®nally to adenocarcinomas, involves the functional loss of tumor-suppressor genes such as APC (adenomatous polyposis coli), DCC (deleted in colon carcinoma), and the p53 tumor-suppressor gene (Fearon and Vogelstein 1990; Vogelstein and Kinzler 1993).”
BackgroundSpecific Association of Human Telomerase Activity with Immortal Cells and Cancer
Kim, N. W., Piatyszek, M. A., Prowse, K. R., Harley, C. B., West, M. D., Ho, P. L. C., Coviello, G. M., Wright, W. E., Weinrich, S. L., & Shay, J. W. (1994) · Science · doi:10.1126/science.7605428 · Cited by 7,091 · cited 8×
“Tissue samples were homogenized in 100 ll ice-cold 3-[3cholamidopropyl)dimethylamino]-propane sulfate (CHAPS), lysis buAer, using Eppendorf tubes and micropestles rotated by a drill at 450 rpm (Eppendorf, Hamburg, Germany) as described ( Kim et al. 1994 ).”
MethodResultInfluentialIdentification of a specific telomere terminal transferase activity in tetrahymena extracts
Greider, C. W., & Blackburn, E. H. (1985) · Cell · doi:10.1016/0092-8674(85)90170-9 · Cited by 3,400 · cited 2×
“the specialized structures containing unique repetitive sequences (TTAGGG in vertebrates) at the end of chromosomes ( Greider and Blackburn 1985, 1989 ).”
BackgroundA survey of telomerase activity in human cancer
Shay, J. W., & Bacchetti, S. (1997) · European Journal of Cancer · doi:10.1016/s0959-8049(97)00062-2 · Cited by 2,794 · cited 4×
“Since that time a great number of tumors of diAerent locations have been analyzed and about 85% have been found to be telomerase-positive (for review see Shay and Bacchetti 1997 ).”
BackgroundInfluentialThe multistep nature of cancer
Vogelstein, B., & Kinzler, K. W. (1993) · Trends in Genetics · doi:10.1016/0168-9525(93)90209-z · Cited by 1,853 · cited 2×
“…from normal epithelium to adenomas, and ®nally to adenocarcinomas, involves the functional loss of tumor-suppressor genes such as APC (adenomatous polyposis coli), DCC (deleted in colon carcinoma), and the p53 tumor-suppressor gene (Fearon and Vogelstein 1990; Vogelstein and Kinzler 1993).”
BackgroundOlovnikov (1973) · doi:10.1016/0022-5193(73)90198-7 · Cited by 1,847 · cited 2×
“The enzyme compensates for the natural telomere erosion due to the inability of the DNA polymerase to replicate linear chromosomes completely (Watson 1972; Olovnikov 1973).”
BackgroundA telomeric sequence in the RNA of Tetrahymena telomerase required for telomere repeat synthesis
Greider, C. W., & Blackburn, E. H. (1989) · Nature · doi:10.1038/337331a0 · Cited by 1,643 · cited 1×
“Telomerase is a ribonucleprotein complex that elongates telomeres, i.e. the specialized structures containing unique repetitive sequences (TTAGGG in vertebrates) at the end of chromosomes (Greider and Blackburn 1985, 1989).”
BackgroundWATSON, J. D. (1972) · Nature New Biology · doi:10.1038/newbio239197a0 · Cited by 1,632 · cited 2×
“The enzyme compensates for the natural telomere erosion due to the inability of the DNA polymerase to replicate linear chromosomes completely (Watson 1972; Olovnikov 1973).”
BackgroundActivation of telomerase in human lymphocytes and hematopoietic progenitor cells
Hiyama, K., Hirai, Y., Kyoizumi, S., Akiyama, M., Hiyama, E., Piatyszek, M. A., Shay, J. W., Ishioka, S., & Yamakido, M. (1995) · The Journal of Immunology · doi:10.4049/jimmunol.155.8.3711 · Cited by 853 · cited 3×
“The majority of samples from esophagus, stomach, and colon were negative (Takubo et al. 1997; Maruyama et al. 1997; Tahara et al. 1995; Ahn et al. 1997; Hiyama E. et al. 1995; Chadeneau et al. 1995; Yoshida et al. 1997), while Hiyama and coworkers were able to demonstrate telomerase activity in all colon samples of he…”
MethodInfluentialTelomerase activity in normal and malignant hematopoietic cells
Broccoli, D., Young, J. W., & de Lange, T. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.20.9082 · Cited by 567 · cited 1×
“As the ®rst example, telomerase activity was reported to be present in peripheral, cord blood, and bone marrow leukocytes (Counter et al. 1995; Broccoli et al. 1995; Hiyama K. et al. 1995).”
Background
Cited by
Telomeres and telomerase in cancer
Artandi, S. E., & DePinho, R. A. (2010) · Carcinogenesis · doi:10.1093/carcin/bgp268 · Cited by 823
Telomerase in the human organism
Collins, K., & Mitchell, J. R. (2002) · Oncogene · doi:10.1038/sj.onc.1205083 · Cited by 603
“…tract and endometrium (Yasumoto et al., 1996; Taylor et al., 1996; HaÈ rle-Bachor and Boukamp, 1996; Hiyama et al., 1996; RamõÂ rez et al., 1997; Tanaka et al., 1998; Yokoyama et al., 1998; Bachor et al., 1999); and a subset of cells in the testis (Wright et al., 1996; Yashima et al., 1998).”
BackgroundThe molecular biology of cancer
Bertram, J. S. (2000) · Molecular Aspects of Medicine · doi:10.1016/s0098-2997(00)00007-8 · Cited by 585
Telomere lengths are characteristic in each human individual
Takubo, K., Izumiyama-Shimomura, N., Honma, N., Sawabe, M., Arai, T., Kato, M., Oshimura, M., & Nakamura, K.-I. (2002) · Experimental Gerontology · doi:10.1016/s0531-5565(01)00218-2 · Cited by 326
Mechanisms of Ultraviolet (UV) B and UVA Phototherapy
Krutmann, J., & Morita, A. (1999) · Journal of Investigative Dermatology Symposium Proceedings · doi:10.1038/sj.jidsp.5640185 · Cited by 169
Genetic pathways involved in the progression of Barrett's metaplasia to adenocarcinoma
Jenkins, G. J. S., Doak, S. H., Parry, J. M., D'Souza, F. R., Griffiths, A. P., & BAXTER, J. N. (2002) · British journal of surgery · doi:10.1046/j.1365-2168.2002.02107.x · Cited by 129
Majumdar, A. S., Hughes, D. E., Lichtsteiner, S., Wang, Z., LEBKOWSKI, J. S., & Vasserot, A. P. (2001) · Gene Therapy · doi:10.1038/sj.gt.3301421 · Cited by 128
Changes of telomere length with aging
Takubo, K., Aida, J., Izumiyama‐Shimomura, N., Ishikawa, N., Sawabe, M., Kurabayashi, R., Shiraishi, H., Arai, T., & Nakamura, K. (2010) · Geriatrics & Gerontology International · doi:10.1111/j.1447-0594.2010.00605.x · Cited by 103
A second chance for telomerase reverse transcriptase in anticancer immunotherapy
Zanetti, M. (2016) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2016.67 · Cited by 109
Prevalence of Telomerase Activity in Human Cancer
Chen, C., & Chen, R. (2011) · Journal of the Formosan Medical Association · doi:10.1016/s0929-6646(11)60043-0 · Cited by 102
Palanca-Wessels, M. C., Klingelhutz, A. J., Reid, B. J., Norwood, T. H., Opheim, K. E., Paulson, T. G., Feng, Z., & Rabinovitch, P. S. (2003) · Carcinogenesis · doi:10.1093/carcin/bgg076 · Cited by 76
The many faces of telomerase: emerging extratelomeric effects
Bollmann, F. M. (2008) · BioEssays · doi:10.1002/bies.20793 · Cited by 74
Shared Phenotypes Among Segmental Progeroid Syndromes Suggest Underlying Pathways of Aging
Hofer, A. C., Tran, R. T., Aziz, O. Z., Wright, W., Novelli, G., Shay, J., & Lewis, M. (2005) · The Journals of Gerontology Series A: Biological Sciences and Medical Sciences · doi:10.1093/gerona/60.1.10 · Cited by 70
“highly replicative cells of skin (11), gastrointestinal tractstomach-intestine (12), bone marrow (13), testes (14), and generally in all systems affected in the telomerase disorder, Dyskeratosis Congenita.”
BackgroundShammas, M. A., Koley, H., Beer, D. G., Li, C., Goyal, R. K., & Munshi, N. C. (2004) · Gastroenterology · doi:10.1053/j.gastro.2004.01.026 · Cited by 75
Intrinsic ageing of gut epithelial stem cells
Kirkwood, T. B. L. (2004) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2004.09.004 · Cited by 67
‘Senescence‐associated’ β‐galactosidase activity in the upper gastrointestinal tract
Going, J. J., Stuart, R. C., Downie, M., Fletcher‐Monaghan, A. J., & Nicol Keith, W. (2002) · The Journal of Pathology · doi:10.1002/path.1059 · Cited by 61
“Another possible difference is suggested by studies of telomerase activity which show consistent positivity by TRAP assay in oesophageal squamous epithelium [14]; this could prevent the triggering of senescence mechanisms associated with telomere shortening.”
BackgroundClinical usefulness of telomerase activation and telomere length in head and neck cancer
Patel, M. M., Parekh, L. J., Jha, F. P., Sainger, R., Patel, J. B., Patel, D. D., Shah, P. M., & Patel, P. S. (2002) · Head & Neck · doi:10.1002/hed.10169 · Cited by 54
Frolkis, M., Fischer, M. B., Wang, Z., LEBKOWSKI, J. S., Chiu, C., & Majumdar, A. S. (2003) · Cancer Gene Therapy · doi:10.1038/sj.cgt.7700563 · Cited by 58
Reynoso, R., Wieser, M., Ojeda, D. S., Bönisch, M., Kühnel, H., Bolcic, F., Quendler, H., Grillari, J., Grillari‐Voglauer, R., & Quarleri, J. F. (2012) · Journal of Virology · doi:10.1128/jvi.01495-12 · Cited by 61
Vonderheide, R. H., Kraynyak, K. A., Shields, A. F., McRee, A. J., Johnson, J. M., Sun, W., Chintakuntlawar, A. V., Pawlicki, J. M., Sylvester, A. J., McMullan, T., et al. (2021) · Journal for ImmunoTherapy of Cancer · doi:10.1136/jitc-2021-003019 · Cited by 47
Krunic, D., Moshir, S., Greulich-Bode, K. M., Figueroa, R., Cerezo, A., Stammer, H., Stark, H.-J., Gray, S. G., Nielsen, K. V., Hartschuh, W., et al. (2009) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2009.02.005 · Cited by 40
Self-citationTelomerase activity in oral and maxillofacial tumors
Liao, J. (2000) · Oral Oncology · doi:10.1016/s1368-8375(00)00013-0 · Cited by 39
“Some reports showed that telomerase activity was detectable in many actively proliferating somatic cells and supported the hypothesis that all continuously proliferating epithelia were telomerase-positive [7,20, 22,23].”
BackgroundTelomere Length Among the Elderly and Oldest-Old
Bischoff, C., Graakjaer, J., Petersen, H. C., Jeune, B., Bohr, V. A., Koelvraa, S., & Christensen, K. (2005) · Twin Research and Human Genetics · doi:10.1375/183242705774310079 · Cited by 39
“So far active telomerase has been observed in normal somatic cells such as lymphocytes, stem cells in the skin and in intestinal mucosa (Bachor et al., 1999; Broccoli et al., 1995; Counter et al., 1995; Harle-Bachor & Boukamp, 1996; Wright et al., 1996).”
BackgroundAgeing mechanisms: the role of telomere loss
Boukamp, P. (2001) · Clinical and Experimental Dermatology · doi:10.1046/j.1365-2230.2001.00903.x · Cited by 43
Self-citationCerezo, A., Stark, H., Moshir, S., & Boukamp, P. (2003) · Journal of Investigative Dermatology · doi:10.1046/j.1523-1747.2003.12304.x · Cited by 41
Self-citationShammas, M. A., Qazi, A. M., Batchu, R. B., Bertheau, R. C., Wong, J. Y. Y., Rao, M. Y., Prasad, M., Chanda, D., Ponnazhagan, S., Anderson, K. C., et al. (2008) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-08-0473 · Cited by 41
Telomere-Dependent Chromosomal Instability
Boukamp, P., Popp, S., & Krunic, D. (2005) · Journal of Investigative Dermatology Symposium Proceedings · doi:10.1111/j.1087-0024.2005.200401.x · Cited by 39
Self-citationCabuy, E., & Ridder, L. D. (2001) · Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin · doi:10.1007/s004280100466 · Cited by 46
“Proteins may be present in this connective tissue that inhibit Taq polymerase activity and prevent amplification of telomerase products [2].”
BackgroundThe role of melatonin on gastric mucosal cell proliferation and telomerase activity in ageing
AKBULUT, K. G., Gönül, B., & Akbulut, H. (2009) · Journal of Pineal Research · doi:10.1111/j.1600-079x.2009.00715.x · Cited by 32
“Although telomerase activity was usually reported to be present in peripheral blood and bone marrow leukocytes, epidermis, endometrium and germ cells [15, 16], conflicting results have been reported for the gastrointestinal mucosa [17, 18].”
ResultGoing, J. J., Fletcher‐Monaghan, A. J., Neilson, L. J., Wisman, B. A., van der Zee, A. G. J., Stuart, R. C., & Keith, W. N. (2004) · PubMed Central · Cited by 27
Telomeres rather than telomerase a key target for anti‐cancer therapy?
Boukamp, P., & Mirancea, N. (2006) · Experimental Dermatology · doi:10.1111/j.1600-0625.2006.00517.x · Cited by 26
Self-citationTelomerase Activity in Periampullary Tumors Correlates With Aggressive Malignancy
Balcom, J. H., Keck, T., Warshaw, A. L., Antoniu, B. A., Graeme‐Cook, F., & Castillo, C. F. F.-D. (2001) · Annals of Surgery · doi:10.1097/00000658-200109000-00008 · Cited by 27
Bollmann, F. M. (2013) · Medical Hypotheses · doi:10.1016/j.mehy.2013.04.028 · Cited by 27
“Moreover, while telomerase activity, as required for telomere lengthening, is negligible in most somatic cells, low-level hTERT expression has been found in a wide range of normal cells, including differentiated epithelial cells [39,40], breast tissue [41], liver cells [42] and normal fibroblasts [43].”
BackgroundTelomerase activity in small cell esophageal carcinoma
Chow, V., Law, S. Y.-K., Lam, A. K.-Y., Luk, J. M., & Wong, J. S. L. (2001) · Diseases of the Esophagus · doi:10.1046/j.1442-2050.2001.00172.x · Cited by 25
GERD is associated with shortened telomeres in the squamous epithelium of the distal esophagus
Souza, R. F., Lunsford, T. N., Ramirez, R. D., Zhang, X., Lee, E. L., Shen, Y., Owen, C. C., Shay, J. W., Morales, C. P., & Spechler, S. J. (2007) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00055.2007 · Cited by 23
“Telomerase activity is found in epithelial cells that maintain their proliferative capacities, whereas telomerase activity usually is absent in connective tissues (2, 10).”
BackgroundTanaka, H., Beam, M. J., & Caruana, K. (2014) · Neoplasia · doi:10.1016/j.neo.2014.08.009 · Cited by 19
“This result suggested that the upregulation of telomerase activity was associated with the presence of known genetic changes, and corroborated an existing idea that the full activation of telomerase could be a late event in colorectal carcinogenesis [80–83].”
ResultTelomerase, hTERT and splice variants in Barrett??s oesophagus and oesophageal adenocarcinoma
Barclay, J., Morris, A. G., & Nwokolo, C. U. (2005) · European Journal of Gastroenterology & Hepatology · doi:10.1097/00042737-200502000-00014 · Cited by 19
Leufke, C., Leykauf, J., Krunic, D., Jauch, A. T., Holtgreve-Grez, H., Böhm‐Steuer, B., Bröcker, E.-B., Mauch, C., Utikal, J. S., Hartschuh, W., et al. (2013) · Oncogene · doi:10.1038/onc.2013.323 · Cited by 21
Self-citationŠvec, J., Musílková, J., Bryndová, J., Jirásek, T., Mandys, V., Kment, M., & Pácha, J. (2009) · Inflammatory Bowel Diseases · doi:10.1002/ibd.21178 · Cited by 17
“Age (years) 70 (28-83) 63 (50-86) 69 (56-83)”
Telomerase: diagnostics, cancer therapeutics and tissue engineering
Ouellette, M. M., & Lee, K. (2001) · Drug Discovery Today · doi:10.1016/s1359-6446(01)02052-9 · Cited by 14
Panarese, S., Brunetti, B., & Sarli, G. (2006) · Journal of Veterinary Diagnostic Investigation · doi:10.1177/104063870601800407 · Cited by 12
Telomerase activity in head and neck cancer.
Kunická, Z., Mucha, I., & Fajkus, J. (2008) · PubMed · Cited by 19
Telomerase activity and expression of human telomerase catalytic subunit gene in esophageal tissues
Tominaga, T., Kashimura, H., Suzuki, K., Nakahara, A., Tanaka, N., Noguchi, M., Itabashi, M., & Ohkawa, J. (2002) · Journal of Gastroenterology · doi:10.1007/s005350200061 · Cited by 10
Immunohistochemical telomeric-repeat binding factor-1 expression in gastrointestinal tumors.
Aragona, M., Buda, C. A., Panetta, S., Morelli, M., Giudice, A. L., Campagna, F., Pontoriero, A., Cascinu, S., & Torre, F. L. (2000) · Oncology Reports · doi:10.3892/or.7.5.987 · Cited by 11
Telomerase Activity in Chronic Inflammatory Bowel Disease
Kleideiter, E., Friedrich, U. A., Möhring, A., Walker, S., Höring, E., Maier, K., Fritz, P., Thon, K., & Klotz, U. E. (2003) · Digestive Diseases and Sciences · doi:10.1023/b:ddas.0000007871.86129.4a · Cited by 8
“with functional losses of tumor-suppressor genes and mutations of oncogenes (21).”
BackgroundInfluentialBisson, F., Paquet, C., Bourget, J., Zaniolo, K., Rochette, P. J., Landreville, S., Damour, O., Boudreau, F., Auger, F. A., Guérin, S. L., et al. (2014) · Journal of Cellular Physiology · doi:10.1002/jcp.24706 · Cited by 9
“While telomerase is active in 85–90% of all tumors, it is inactive in most somatic cells (Kim et al., 1994), except for those that are found in regenerating tissues such as the hematopoietic system and the epidermis (Harle-Bachor and Boukamp, 1996; Bachor et al., 1999; Cerezo et al., 2003).”
BackgroundCellular turnover of normal gastrointestinal epithelium assessed by changes in telomeric
Craig, W. L., McKinlay, A., & Vickers, M. A. (2003) · European Journal of Gastroenterology & Hepatology · doi:10.1097/00042737-200311000-00008 · Cited by 7
Prognostic Alternative Splicing Signatures in Esophageal Carcinoma
Dlamini, Z., Hull, R., Mbatha, S. Z., Alaouna, M., Qiao, Y., Yu, H., & Chatziioannou, A. A. (2021) · Cancer Management and Research · doi:10.2147/cmar.s305464 · Cited by 7
“activity was 3 times lower in the Barrett's esophagus in contrast to normal mucosa.(133) Quantitative RT-PCR showed that htert”
ResultDetection of Telomerase Enzyme Activity by TRAP Assay
Keith, W. N., & Monaghan, A. (2004) · Humana Press eBooks · doi:10.1385/1-59259-760-2:311 · Cited by 5
Inai, M., Kano, M., Shimada, Y., Sakurai, T., Chiba, T., & Imamura, M. (2001) · British Journal of Cancer · doi:10.1038/sj.bjc.6692032 · Cited by 3
Telomerase as a Potential Regulator of Tissue Progenitor Cells
Artandi, S. E. (2007) · Springer eBooks · doi:10.1007/978-3-540-73709-4_10 · Cited by 3
Shammas, M. A., & Rao, M. Y. (2011) · Methods in molecular biology · doi:10.1007/978-1-61779-163-5_14 · Cited by 2
Krsmanovic, P. (2011) · Medical Hypotheses · doi:10.1016/j.mehy.2011.05.027 · Cited by 2
“Most of eukaryotes have an enzyme called telomerase to counteract the telomere shortening, which is expressed in only a subset of cell types in multicellular organisms, such as gametes as well as most of cancer cells [49].”
BackgroundUstaoğlu, M., Bektaş, A., Bedir, A., Bakir, T., Düzgün, A., Nar, R., Ecemiş, Ö., & Aslan, R. (2020) · Archives of Medical Science · doi:10.5114/aoms.2020.94656 · Cited by 2
“In a number of studies, telomerase enzyme activity was found in peripheral blood, cord blood, bone marrow leucocytes, basal layer of epidermis, endometrium, and chorionic villi [5].”
BackgroundKANSER TANI VE TEDAVİSİNDE DNA’YA YÖNELİK GÜNCEL YAKLAŞIMLAR: TELOMERAZ / TERT
TİRYAKİOĞLU, A. E., ÖZKAN, M., KAYIM, S., Bağcı, Ö., Çeviker, K., Tatar, B., Yazkan, R., & Erdemoğlu, E. (2016) · Mühendislik Bilimleri ve Tasarım Dergisi · doi:10.21923/jesd.04365 · Cited by 2
Biological Clocks in the Aging Cell
Boukamp, P. (2003) · Springer eBooks · doi:10.1007/978-94-017-0667-4_8 · Cited by 3
Self-citationTelomeraz Enziminin Tanı ve Tedavide Kullanım Alanı
Güzelgül, F., & Aksoy, K. (2011) · DergiPark (Istanbul University) · doi:10.17827/aktd.08619
Hultdin, M. (2003) · DiVA (Digitala Vetenskapliga Arkivet) · Cited by 1
Anti-Aging Medicine LiteratureWatch
Pawelec, G. (1998) · Rejuvenation Research · doi:10.1089/rej.1.1998.1.275
Neoplasia of the Gastrointestinal Tract
Margalit, O., & DuBois, R. N. (2015) · Wiley eBooks · doi:10.1002/9781118512074.ch31
Keçilerin Enzootik Intranazal Tümörlerinde Telomeraz Enziminin Düzeyinin Belirlenmesi
Şahinduran, Ş., Özmen, Ö., & KIYICI, R. (2018) · Kafkas Universitesi Veteriner Fakultesi Dergisi · doi:10.9775/kvfd.2018.19678
Shimada, Y., Inai, M., Kano, M., Sakurai, T., Chiba, T., & Imamura, M. (2002) · Springer eBooks · doi:10.1007/978-4-431-67873-1_26
Wijnhoven, B. P. L., & Dinjens, W. N. M. (2001) · Springer eBooks · doi:10.1007/978-94-017-0829-6_14
Anti-Aging Medicine LiteratureWatch
Pawelec, G. (1999) · Rejuvenation Research · doi:10.1089/rej.1.1999.2.295
Poustka, A., & Heiss, N. S. (2003) · CRC Press eBooks · doi:10.1201/9780203911709.ch15 · Cited by 1
Ramirez, R. D. (2007) · Humana Press eBooks · doi:10.1007/978-1-59745-221-2_8
“In support of this concept, recent reports have demonstrated the presence of telomerase activity in hematopoietic progenitor cells and activated lymphocytes (70–72), the epidermis (73,74), and the intestine ( 75 ).”
Background
Metadata
- Authors
- Bachor, C., Bachor, O. A., & Boukamp, P.
- Affiliations
- German Cancer Research Center (DE)
- Klinikum Ludwigshafen (DE)
- ORCID
- Boukamp, Petra
- Venue
- Journal of Cancer Research and Clinical Oncology
- Published
- 1999-08-06
- Volume
- 125
- Issue
- 8-9
- Pages
- 453-460
- ISSN
- 0084-5353 (ISSN-L)
- 0171-5216
- 1432-1335
- PMC
- PMC12172385
- OpenAlex
- W2016779153
- Cited by
- 68
- References
- 30
- Citations by year
- 2021: 2 · 2020: 1 · 2018: 1 · 2016: 2 · 2015: 2 · 2014: 2 · 2013: 3 · 2012: 1
- FWCI
- 3.78
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Journal of Cancer Research and Clinical Oncology (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Telomeres, Telomerase, and Senescence
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Aging › Genetics, Aging, and Longevity in Model Organisms
- Health Sciences › Medicine › Surgery › Esophageal Cancer Research and Treatment
- Keywords
- telomerase, gastrointestinal mucosa, precancerous lesions, Barrett's esophagus, intestinal metaplasia, colorectal adenoma, adenocarcinoma, telomere repeat amplification protocol, carcinogenesis, esophagus, stomach, intestine, telomerase inhibitors
- MeSH terms
- Adult, Aged, Aged, 80 and over, Female, Gastric Mucosa, Gastrointestinal Neoplasms, Gene Amplification, Humans, Intestinal Mucosa, Male, Middle Aged, Up-Regulation, Gene Expression Regulation, Neoplastic, Telomerase
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.